All News LumiraDx Limited

Equities

Delayed OTC Markets Other stock markets 20:12:20 30/04/2024 BST			5-day change	1st Jan Change
0.022 ^USD	+41.94%		+46.67%	-65.02%

01-08	Top Midday Decliners	MT
01-08	LumiraDx Limited(OTCPK:LMDX.F) dropped from NASDAQ Composite Index	CI

Top Midday Decliners	01-08	MT
Stocks Commence 2024 Bullish Rally: LMDX, HNRC, BULT, HALB, SPZI	01-08	AQ
LumiraDx Limited(OTCPK:LMDX.F) dropped from NASDAQ Composite Index	01-08	CI
LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th	01-05	GL
Wall Street Set to Open 2024 Lower Amid Rise in Oil Prices, Ahead of Manufacturing, Construction Data	01-02	MT
Top Premarket Decliners	01-02	MT
Roche enters into a definitive agreement to acquire LumiraDx's Point of Care technology combining multiple diagnostic modalities on a single platform	01-02	AQ
Roche to buy part of LumiraDx diagnostics platform for $295 million	12-29	RE
LumiraDx Agrees to Sell Point-of-Care Tech Platform to Roche	12-29	DJ
LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche	12-29	GL
LumiraDx : EXPLANATORY NOTE - Form 6-K	12-29	PU
LumiraDx : EXPLANATORY NOTE - Form 6-K	12-11	PU
Wall Street Set to Open Lower Friday as Investors Await Economic Data, Powell Speech	12-01	MT
Investors Look Ahead to Powell Speech as US Futures Trend Lower Friday	12-01	MT
Top Premarket Decliners	12-01	MT
LumiraDx : EXPLANATORY NOTE - Form 6-K	11-21	PU
LumiraDx Limited Announces Resignation of Lu Huang from the Board of Directors	11-07	CI
LumiraDx : EXPLANATORY NOTE - Form 6-K	11-06	PU
LumiraDx Limited Announces Board Appointments	11-06	CI
LumiraDx Limited Appoints Veronique Ameye as the Company?s Chief Executive Officer and General Counsel, Effective as of November 1, 2023	11-06	CI

No results for this search